Those older signals came from observational data, where the men prescribed these drugs were often heavier and sicker to begin with exactly the patients who form stones anyway
On November 8, 2023, the FDA approved Tirzepatide under the brand name Zepbound for chronic weight management in adults with obesity (Body Mass Index 30 kg/m) or with overweight (BMI 27 kg/m) who have at least one weight-related comorbid condition, such as hypertension, dyslipidemia, or T2D
Development and validation of a new score to assess the risk of posttransplantation diabetes mellitus in kidney transplant recipients
Diastolic blood pressure reductions tend to be smaller, reinforcing the importance of continuing guideline-directed antihypertensive treatment
Define Your Target Customer Segment Consider demographics (age, gender), hair type (fine, thick, curly, straight, oily, dry, color-treated), and primary concerns (hair loss, dandruff, dryness, volume, color care)